Painson J C, Tannenbaum G S
Endocrinology. 1985 Sep;117(3):1132-8. doi: 10.1210/endo-117-3-1132.
We examined the effects of 2-deoxy-D-glucose (2DG)-induced intracellular glucoprivation on GH, insulin, and glucose secretory dynamics in freely moving rats bearing chronic intracerebroventricular and intracardiac venous cannulae. Intravenous administration of 2DG (400 mg/kg) caused a severe suppression in amplitude and duration of spontaneous GH surges; plasma GH levels remained significantly depressed for at least 5 h in the presence of marked hyperglycemia. Plasma insulin levels were unchanged. Central administration of a low dose of 2DG (8 mg/10 microliters) also markedly attenuated GH pulse amplitude and raised plasma glucose levels, but this low dose was without effect when injected peripherally, suggesting a central site of action. To elucidate the mechanism(s) mediating the GH suppression response to insufficient glucose we assessed the involvement of the two hypothalamic GH-regulatory peptides, somatostatin (SRIF) and GH-releasing factor (GRF). Passive immunization of 2DG-treated rats with a specific SRIF antiserum (AS) caused an initial surge of GH release and significant elevation of both trough and mean 6-h plasma GH levels, compared to 2DG-normal sheep serum controls. However, SRIF AS failed to restore the amplitude of GH pulses to normal levels. Administration of three iv boluses of human GRF (10 micrograms), at 90-min intervals, to 2DG-treated rats resulted in GH release which was variable and time dependent; the magnitude of the first response (1 h after 2DG injection) was significantly less than that of the other two. Immunoneutralization with SRIF AS eliminated this difference and significantly enhanced human GRF-induced GH release. These results demonstrate that intracellular glucopenia is a potent inhibitor of pulsatile GH secretion in the rat and that this response is mediated, in part, by an increase in SRIF release. While the present findings are compatible with the hypothesis that glucoprivation induces an acute SRIF release, only a partial role for SRIF is indicated in this response. The longer lasting suppression of GH pulses observed after glucose deprivation may be due to decreased output of GRF from the hypothalamus.
我们研究了2-脱氧-D-葡萄糖(2DG)诱导的细胞内糖缺乏对携带慢性脑室内和心内静脉插管的自由活动大鼠生长激素(GH)、胰岛素和葡萄糖分泌动力学的影响。静脉注射2DG(400mg/kg)导致自发性GH激增的幅度和持续时间严重抑制;在明显高血糖的情况下,血浆GH水平至少5小时仍显著降低。血浆胰岛素水平未改变。中枢给予低剂量的2DG(8mg/10微升)也显著减弱了GH脉冲幅度并升高了血浆葡萄糖水平,但该低剂量经外周注射时无效,提示其作用部位在中枢。为了阐明介导GH对葡萄糖不足抑制反应的机制,我们评估了两种下丘脑GH调节肽,生长抑素(SRIF)和生长激素释放因子(GRF)的参与情况。与2DG - 正常羊血清对照组相比,用特异性SRIF抗血清(AS)对2DG处理的大鼠进行被动免疫导致初始GH释放激增以及谷值和6小时平均血浆GH水平显著升高。然而,SRIF抗血清未能将GH脉冲幅度恢复到正常水平。以90分钟的间隔向2DG处理的大鼠静脉注射三次人GRF(10微克),导致GH释放具有变异性且依赖时间;第一次反应(2DG注射后1小时)的幅度明显小于其他两次。用SRIF抗血清进行免疫中和消除了这种差异,并显著增强了人GRF诱导的GH释放。这些结果表明,细胞内低血糖是大鼠脉冲式GH分泌的有效抑制剂,并且这种反应部分是由SRIF释放增加介导的。虽然目前的研究结果与糖缺乏诱导急性SRIF释放的假设一致,但在这种反应中仅表明SRIF起部分作用。葡萄糖剥夺后观察到的GH脉冲的持续时间更长的抑制可能是由于下丘脑GRF输出减少所致。